Validity of SYNTAX score II for risk stratification of percutaneous coronary interventions:A patient-level pooled analysis of 5433 patients enrolled in contemporary coronary stent trials

International Journal of Cardiology

Volumn 187, Issue 1, 2015, Pages 111-115

  Campos, Carlos M ^a,b   Garcia Garcia, Hector M ^a,c   Van Klaveren, David ^a   Ishibashi, Yuki ^a   Cho, Yun Kyeong ^a   Valgimigli, Marco ^a   Räber, Lorenz ^d   Jonker, Hans ^c   Onuma, Yoshinobu ^a   Farooq, Vasim ^a   Garg, Scot ^e   Windecker, Stephan ^d   Morel, Marie Angele ^c   Steyerberg, Ewout W ^a   Serruys, Patrick W ^a,f  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

^c CARDIALYSIS   (Netherlands)

^d UNIVERSITY OF BERN   (Switzerland)

^e EAST LANCASHIRE HOSPITALS NHS TRUST   (United Kingdom)

^f IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

Drug eluting stent; Percutaneous coronary intervention; Risk stratification; SYNTAX score; SYNTAX score Ii

Indexed keywords

ADULT; ARTICLE; ATTRIBUTABLE RISK; CARDIOVASCULAR DISEASE ASSESSMENT; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; CORONARY STENT; DRUG ELUTING STENT; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; PATIENT CODING; PERCUTANEOUS CORONARY INTERVENTION; PREDICTION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RISK ASSESSMENT; SYNTAX SCORE II; VALIDITY; CLINICAL TRIAL; CORONARY ARTERY DISEASE; HEALTH; MIDDLE AGED; MULTICENTER STUDY; PROCEDURES; SURVIVAL RATE; TIME FACTOR; TREATMENT OUTCOME; TRENDS;

CORONARY ARTERY DISEASE; DRUG-ELUTING STENTS; FEMALE; FOLLOW-UP STUDIES; GLOBAL HEALTH; HUMANS; MALE; MIDDLE AGED; PERCUTANEOUS CORONARY INTERVENTION; SURVIVAL RATE; TIME FACTORS; TREATMENT OUTCOME;

EID: 84929333028     PISSN: 01675273     EISSN: 18741754     Source Type: Journal    
DOI: 10.1016/j.ijcard.2015.03.248     Document Type: Article

References (29)

1. G. Sianos, M.A. Morel, A.P. Kappetein, M.C. Morice, A. Colombo, K. Dawkins, M. van den Brand, N. Van Dyck, M.E. Russell, F.W. Mohr, P.W. Serruys, The syntax score: an angiographic tool grading the complexity of coronary artery disease, EuroIntervention 1 (2005) 219-227.
2. P.W. Serruys, M.C. Morice, A.P. Kappetein, A. Colombo, D.R. Holmes, M.J. Mack, E. Stahle, T.E. Feldman, M. van den Brand, E.J. Bass, N. Van Dyck, K. Leadley, K.D. Dawkins, F.W. Mohr, S. Investigators, Percutaneous coronary intervention versus coronary-artery bypass grafting for severe coronary artery disease, N. Engl. J. Med. 360 (2009) 961-972.
3. P.W. Serruys, Y. Onuma, S. Garg, G. Sarno, M. van den Brand, A.P. Kappetein, N. Van Dyck, M. Mack, D. Holmes, T. Feldman, M.C. Morice, A. Colombo, E. Bass, K. Leadley, K.D. Dawkins, G.A. van Es, M.A. Morel, F.W. Mohr, Assessment of the syntax score in the syntax study, EuroIntervention 5 (2009) 50-56.
4. A.P. Kappetein, T.E. Feldman, M.J. Mack, M.C. Morice, D.R. Holmes, E. Stahle, K.D. Dawkins, F.W. Mohr, P.W. Serruys, A. Colombo, Comparison of coronary bypass surgery with drug-eluting stenting for the treatment of left main and/or three-vessel disease: 3-year follow-up of the syntax trial, Eur. Heart J. 32 (2011) 2125-2134.
5. F.W. Mohr, M.C. Morice, A.P. Kappetein, T.E. Feldman, E. Stahle, A. Colombo, M.J. Mack, D.R. Holmes Jr., M.A. Morel, N. Van Dyck, V.M. Houle, K.D. Dawkins, P.W. Serruys, Coronary artery bypass graft surgery versus percutaneous coronary intervention in patients with three-vessel disease and left main coronary disease: 5-year follow-up of the randomised, clinical syntax trial, Lancet 381 (2013) 629-638.
6. W. Wijns, P. Kolh, N. Danchin, C. Di Mario, V. Falk, T. Folliguet, S. Garg, K. Huber, S. James, J. Knuuti, J. Lopez-Sendon, J. Marco, L. Menicanti, M. Ostojic, M.F. Piepoli, C. Pirlet, J.L. Pomar, N. Reifart, F.L. Ribichini, M.J. Schalij, P. Sergeant, P.W. Serruys, S. Silber, M. Sousa Uva, D. Taggart, Guidelines on myocardial revascularization, Eur. Heart J. 31 (2010) 2501-2555.
7. S.D. Fihn, J.M. Gardin, J. Abrams, K. Berra, J.C. Blankenship, A.P. Dallas, P.S. Douglas, J.M. Foody, T.C. Gerber, A.L. Hinderliter, S.B. King III, P.D. Kligfield, H.M. Krumholz, R.Y. Kwong, M.J. Lim, J.A. Linderbaum, M.J. Mack, M.A. Munger, R.L. Prager, J.F. Sabik, L.J. Shaw, J.D. Sikkema, C.R. Smith Jr., S.C. Smith Jr., J.A. Spertus, S.V. Williams, 2012 ACCF/AHA/ACP/AATS/PCNA/SCAI/STS guideline for the diagnosis and management of patients with stable ischemic heart disease: a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines, and the American College of Physicians, American Association for Thoracic Surgery, Preventive Cardiovascular Nurses Association, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons, J. Am. Coll. Cardiol. 60 (2012) e44-e164.
8. D.N. Feldman, C.L. Gade, A.J. Slotwiner, M. Parikh, G. Bergman, S.C. Wong, R.M. Minutello, Comparison of outcomes of percutaneous coronary interventions in patients of three age groups (<60, 60 to 80, and >80 years) (from the New York State Angioplasty Registry), Am. J. Cardiol. 98 (2006) 1334-1339.
9. P.C. Keelan, J.M. Johnston, T. Koru-Sengul, K.M. Detre, D.O. Williams, J. Slater, P.C. Block, D.R. Holmes Jr., Comparison of in-hospital and one-year outcomes in patients with left ventricular ejection fractions < or =40%, 41% to 49%, and > or =50% having percutaneous coronary revascularization, Am. J. Cardiol. 91 (2003) 1168-1172.
10. J.A. Shaw, N. Andrianopoulos, S. Duffy, A.S. Walton, D. Clark, R. Lew, M. Sebastian, G. New, A. Brennan, C. Reid, A.E. Ajani, Renal impairment is an independent predictor of adverse events post coronary intervention in patients with and without drugeluting stents, Cardiovasc. Revasc. Med. 9 (2008) 218-223.
11. V. Farooq, D. van Klaveren, E.W. Steyerberg, E. Meliga, Y. Vergouwe, A. Chieffo, A.P. Kappetein, A. Colombo, D.R. Holmes Jr., M. Mack, T. Feldman, M.C. Morice, E. Stahle, Y. Onuma, M.A. Morel, H.M. Garcia-Garcia, G.A. van Es, K.D. Dawkins, F.W. Mohr, P.W. Serruys, Anatomical and clinical characteristics to guide decision making between coronary artery bypass surgery and percutaneous coronary intervention for individual patients: development and validation of syntax score ii, Lancet 381 (2013) 639-650.
12. C.M. Campos, D. van Klaveren, V. Farooq, C.A. Simonton, A.P. Kappetein, J.F. Sabik III, E.W. Steyerberg, G.W. Stone, P.W. Serruys, On Behalf of the ETI, Long-term forecasting and comparison of mortality in the evaluation of the Xience Everolimus Eluting Stent vs. Coronary Artery Bypass Surgery for Effectiveness of left Main Revascularization (EXCEL) trial: prospective validation of the Syntax score II, Eur. Heart J. (2015), pii: ehu518. [Epub ahead of print].
13. C.M. Campos, D. van Klaveren, J. Iqbal, Y. Onuma, Y.J. Zhang, H.M. Garcia-Garcia, M.A. Morel, V. Farooq, H. Shiomi, Y. Furukawa, Y. Nakagawa, K. Kadota, P.A. Lemos, T. Kimura, E.W. Steyerberg, P.W. Serruys, Predictive performance of syntax score ii in patients with left main and multivessel coronary artery disease, Circ. J. 78 (2014) 1942-1949.
14. S. Windecker, P. Kolh, F. Alfonso, J.P. Collet, J. Cremer, V. Falk, G. Filippatos, C. Hamm, S.J. Head, P. Juni, A.P. Kappetein, A. Kastrati, J. Knuuti, U. Landmesser, G. Laufer, F.J. Neumann, D.J. Richter, P. Schauerte, M. Sousa Uva, G.G. Stefanini, D.P. Taggart, L. Torracca, M. Valgimigli, W. Wijns, A. Witkowski, 2014 ESC/EACTS guidelines on myocardial revascularization: the task force on myocardial revascularization of the European Society of Cardiology (ESC) and the European Association for Cardiothoracic Surgery (EACTS) developed with the special contribution of the European Association of Percutaneous Cardiovascular Interventions (EAPCI), EuroIntervention 10 (9) (2015) 1024-1094, http://dx.doi.org/10.4244/EIJY14M09-01.
15. P.W. Serruys, S. Silber, S. Garg, R.J. van Geuns, G. Richardt, P.E. Buszman, H. Kelbaek, A.J. van Boven, S.H. Hofma, A. Linke, V. Klauss, W. Wijns, C. Macaya, P. Garot, C. DiMario, G. Manoharan, R. Kornowski, T. Ischinger, A. Bartorelli, J. Ronden, M. Bressers, P. Gobbens, M. Negoita, F. van Leeuwen, S. Windecker, Comparison of zotarolimus-eluting and everolimus-eluting coronary stents, N. Engl. J. Med. 363 (2010) 136-146.
16. S. Windecker, A. Remondino, F.R. Eberli, P. Juni, L. Raber, P. Wenaweser, M. Togni, M. Billinger, D. Tuller, C. Seiler, M. Roffi, R. Corti, G. Sutsch, W. Maier, T. Luscher, O.M. Hess, M. Egger, B. Meier, Sirolimus-eluting and paclitaxel-eluting stents for coronary revascularization, N. Engl. J. Med. 353 (2005) 653-662.
17. S. Windecker, P.W. Serruys, S. Wandel, P. Buszman, S. Trznadel, A. Linke, K. Lenk, T. Ischinger, V. Klauss, F. Eberli, R. Corti, W. Wijns, M.C. Morice, C. di Mario, S. Davies, R.J. van Geuns, P. Eerdmans, G.A. van Es, B. Meier, P. Juni, Biolimus-eluting stent with biodegradable polymer versus sirolimus-eluting stent with durable polymer for coronary revascularisation (leaders): a randomised non-inferiority trial, Lancet 372 (2008) 1163-1173.
18. P.W. Serruys, A.T. Ong, M.C. Morice, B. De Bruyne, A. Colombo, C. Macaya, G. Richardt, J. Fajadet, C. Hamm, K. Dawkins, A.J. O'Malley, M. Bressers, D. Donohoe, Arterial revascularisation therapies study part II - sirolimus-eluting stents for the treatment of patients with multivessel de novo coronary artery lesions, EuroIntervention 1 (2005) 147-156.
19. M. Valgimigli, G. Percoco, P. Malagutti, G. Campo, F. Ferrari, D. Barbieri, G. Cicchitelli, E.P. McFadden, F. Merlini, L. Ansani, G. Guardigli, A. Bettini, G. Parrinello, E. Boersma, R. Ferrari, Tirofiban and sirolimus-eluting stent vs abciximab and bare-metal stent for acute myocardial infarction: a randomized trial, JAMA 293 (2005) 2109-2117.
20. M. Valgimigli, G. Campo, G. Percoco, L. Bolognese, C. Vassanelli, S. Colangelo, N. de Cesare, A.E. Rodriguez, M. Ferrario, R. Moreno, T. Piva, I. Sheiban, G. Pasquetto, F. Prati, M.S. Nazzaro, G. Parrinello, R. Ferrari, Comparison of angioplasty with infusion of tirofiban or abciximab and with implantation of sirolimus-eluting or uncoated stents for acute myocardial infarction: the multistrategy randomized trial, JAMA 299 (2008) 1788-1799.
21. P.W. Serruys, S. Garg, A. Abizaid, J. Ormiston, S. Windecker, S. Verheye, C. Dubois, J. Stewart, K.E. Hauptmann, J. Schofer, K. Stangl, B. Witzenbichler, M. Wiemer, E. Barbato,T.de Vries, A.M. den Drijver, H. Otake, L. Meredith, S. Toyloy, P. Fitzgerald, A randomised comparison of novolimus-eluting and zotarolimus-eluting coronary stents: 9-month follow-up results of the EXCELLA II study, EuroIntervention 6 (2010) 195-205.
22. V. Farooq, D. van Klaveren, E.W. Steyerberg, P.W. Serruys, Syntax score II - authors' reply, Lancet 381 (2013) 1899-1900.
23. J. Iqbal, P.W. Serruys, D.P. Taggart, Optimal revascularization for complex coronary artery disease, Nat. Rev. Cardiol. 10 (2013) 635-647.
24. J.S. Jang, Y.J. Song, W. Kang, H.Y. Jin, J.S. Seo, T.H. Yang, D.K. Kim, K.I. Cho, B.H. Kim, Y.H. Park, H.G. Je, D.S. Kim, Intravascular ultrasound-guided implantation of drugeluting stents to improve outcome: a meta-analysis, JACC Cardiovasc. Interv. 7 (3) (2014) 233-243, http://dx.doi.org/10.1016/j.jcin.2013.09.013.
25. Y.J. Zhang, H.M. Garcia-Garcia, V. Farooq, C.V. Bourantas, P.W. Serruys, S.L. Chen, Revisiting: "Comparison of intravascular ultrasound versus angiography-guided drug-eluting stent implantation: a meta-analysis of one randomised trial and ten observational studies involving 19,619 patients", EuroIntervention 9 (2013) 891-892.
26. V. Farooq, P.W. Serruys, C.V. Bourantas, Y. Zhang, T. Muramatsu, T. Feldman, D.R. Holmes, M. Mack, M.C. Morice, E. Stahle, A. Colombo, T. de Vries, M.A. Morel, K.D. Dawkins, A.P. Kappetein, F.W. Mohr, Quantification of incomplete revascularization and its association with five-year mortality in the synergy between percutaneous coronary intervention with taxus and cardiac surgery (syntax) trial validation of the residual syntax score, Circulation 128 (2013) 141-151.
27. A. Anzai, Y. Maekawa, M. Kodaira, S. Mogi, T. Arai, T. Kawakami, H. Kanazawa, K. Hayashida, S. Yuasa, A. Kawamura, K. Fukuda, Prognostic implications of optimal medical therapy in patients undergoing percutaneous coronary intervention for acute coronary syndrome in octogenarians, Heart Vessels 30 (2) (2015) 186-192.
28. R. Chowdhury, H. Khan, E. Heydon, A. Shroufi, S. Fahimi, C. Moore, B. Stricker, S. Mendis, A. Hofman, J. Mant, O.H. Franco, Adherence to cardiovascular therapy: a meta-analysis of prevalence and clinical consequences, Eur. Heart J. 34 (2013) 2940-2948.
29. J.W. Suh, R. Mehran, B.E. Claessen, K. Xu, U. Baber, G. Dangas, H. Parise, A.J. Lansky, B. Witzenbichler, C.L. Grines, G. Guagliumi, R. Kornowski, J. Wohrle, D. Dudek, G. Weisz, G.W. Stone, Impact of in-hospital major bleeding on late clinical outcomes after primary percutaneous coronary intervention in acute myocardial infarction: the HORIZONS-AMI (Harmonizing Outcomes with Revascularization and Stents in Acute Myocardial Infarction) trial, J. Am. Coll. Cardiol. 58 (2011) 1750-1756.